Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N B Haas

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Seminars in Urologic Oncology|September 20, 2001
Can chemotherapy alter the course of prostate cancer?N B Haas
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Chicken repeat 1 elements contain a pol-like open reading frame and belong to the non-long terminal repeat class of retrotransposonsJ B Burch, D L Davis, N B Haas
Gene|October 23, 1997
Chicken repeat 1 (CR1) elements, which define an ancient family of vertebrate non-LTR retrotransposons, contain two closely spaced open reading framesN B Haas, J M Grabowski, A B Sivitz, et al.
Molecular and Cellular Biology|April 1, 1995
DNA-binding specificity of the PAR basic leucine zipper protein VBP partially overlaps those of the C/EBP and CREB/ATF families and is influenced by domains that flank the core basic regionN B Haas, C A Cantwell, P F Johnson, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancerN B Haas, J Manola, G Hudes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial populationS Buti, M Puligandla, M Bersanelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2018
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial populationS Buti, M Puligandla, M Bersanelli, et al.
Investigational New Drugs|May 1, 1993
Phase I trial of 5-fluorouracil by 24-hour infusion weeklyN B Haas, J B Hines, G R Hudes, et al.
Gene|March 20, 2001
Subfamilies of CR1 non-LTR retrotransposons have different 5'UTR sequences but are otherwise conservedN B Haas, J M Grabowski, J North, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Clinical, pharmacokinetic and biological studies of topotecanP J O'Dwyer, F P LaCreta, N B Haas, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Seminars in Urologic Oncology|September 20, 2001
Can chemotherapy alter the course of prostate cancer?N B Haas
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Chicken repeat 1 elements contain a pol-like open reading frame and belong to the non-long terminal repeat class of retrotransposonsJ B Burch, D L Davis, N B Haas
Gene|October 23, 1997
Chicken repeat 1 (CR1) elements, which define an ancient family of vertebrate non-LTR retrotransposons, contain two closely spaced open reading framesN B Haas, J M Grabowski, A B Sivitz, et al.
Molecular and Cellular Biology|April 1, 1995
DNA-binding specificity of the PAR basic leucine zipper protein VBP partially overlaps those of the C/EBP and CREB/ATF families and is influenced by domains that flank the core basic regionN B Haas, C A Cantwell, P F Johnson, et al.
American Journal of Clinical Oncology|February 24, 2001
Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancerN B Haas, J Manola, G Hudes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial populationS Buti, M Puligandla, M Bersanelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2018
Validation of a new prognostic model to easily predict outcome in renal cell carcinoma: the GRANT score applied to the ASSURE trial populationS Buti, M Puligandla, M Bersanelli, et al.
Investigational New Drugs|May 1, 1993
Phase I trial of 5-fluorouracil by 24-hour infusion weeklyN B Haas, J B Hines, G R Hudes, et al.
Gene|March 20, 2001
Subfamilies of CR1 non-LTR retrotransposons have different 5'UTR sequences but are otherwise conservedN B Haas, J M Grabowski, J North, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Clinical, pharmacokinetic and biological studies of topotecanP J O'Dwyer, F P LaCreta, N B Haas, et al.
Pageof 2